Change in Plaque Characteristics With Atorvastatin

• Status: Completed
• Trial end date: 2012-02-01
• Target enrollment: 0
• Participant gender: All

Summary

To examine effects of intensive lipid lowering therapy with atorvastatin on stabilization of coronary plaque by using optical coherence tomography (OCT) in patients with acute coronary syndrome.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wakayama Medical University
• Treatments: Atorvastatin; Atorvastatin Calcium

Criteria

Inclusion Criteria:

• Patients with acute coronary syndrome (myocardial infarction or unstable angina) who will undergo PCI.

• plasma LDL cholesterol levels : >=100mg/dL and ≤160mg/dL

• at least one atherosclerotic lesion of >25% stenosis other than culprit lesions of current ACS

Exclusion Criteria:

• Patients who will undergo coronary bypass surgery.

• Patients with major complications during treatment of culprit coronary lesions.

• Patients with an atherosclerotic lesion with >50% stenosis at a left main trunk.